A meta-analysis of 17 studies showed that painful, blistering, and/or severe sunburns of medium and high frequencies significantly increase the risk for cutaneous squamous cell carcinoma (cSCC). To ...
The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody Libtayo(cemiplimab-rwlc) as an adjuvant therapy for adults with cutaneous ...